<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D2D9079A-7C22-416E-84A8-4F37FF19A482"><gtr:id>D2D9079A-7C22-416E-84A8-4F37FF19A482</gtr:id><gtr:name>Callaghan Innovation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0CF23EC6-EA76-4813-BB6B-803FF1050B4A"><gtr:id>0CF23EC6-EA76-4813-BB6B-803FF1050B4A</gtr:id><gtr:name>Industrial Research Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/308C1B48-278F-44D4-A65F-12A0D8DE1068"><gtr:id>308C1B48-278F-44D4-A65F-12A0D8DE1068</gtr:id><gtr:name>Victoria University of Wellington</gtr:name><gtr:address><gtr:line1>PO Box 600</gtr:line1><gtr:line4>Wellington</gtr:line4><gtr:postCode>6140</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D2D9079A-7C22-416E-84A8-4F37FF19A482"><gtr:id>D2D9079A-7C22-416E-84A8-4F37FF19A482</gtr:id><gtr:name>Callaghan Innovation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CF23EC6-EA76-4813-BB6B-803FF1050B4A"><gtr:id>0CF23EC6-EA76-4813-BB6B-803FF1050B4A</gtr:id><gtr:name>Industrial Research Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/308C1B48-278F-44D4-A65F-12A0D8DE1068"><gtr:id>308C1B48-278F-44D4-A65F-12A0D8DE1068</gtr:id><gtr:name>Victoria University of Wellington</gtr:name><gtr:address><gtr:line1>PO Box 600</gtr:line1><gtr:line4>Wellington</gtr:line4><gtr:postCode>6140</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8D381AAA-E001-4B4F-8C29-3C468F3AFC6C"><gtr:id>8D381AAA-E001-4B4F-8C29-3C468F3AFC6C</gtr:id><gtr:firstName>Jerry</gtr:firstName><gtr:surname>Turnbull</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G117%2F423"><gtr:id>F7EE2C47-C4CA-426F-B06E-BC901C65C942</gtr:id><gtr:title>Heparan Sulphates as Dynamic Cell Regulators: Structure, Biosynmthesis &amp;amp; Mechanisms of Action of the Neural Heparanome</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G117/423</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1385879</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Callaghan Innovation</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Carbohydrate Chemistry</gtr:department><gtr:description>Development of AD therapeutics</gtr:description><gtr:id>66A0EE68-3EE5-4EC2-8D53-D395DDAC7187</gtr:id><gtr:impact>Chem Eur J publication, further manuscripts in preparation, joint funding and IP patent submissions</gtr:impact><gtr:outcomeId>538307427a76f7.91630409-1</gtr:outcomeId><gtr:partnerContribution>Developing synthetic chemistry for BACE inhibitors and providing compounds and radiolabelled compounds</gtr:partnerContribution><gtr:piContribution>Providing target structures and bioassays</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Animal testing of AD secretase inhibitors</gtr:description><gtr:id>84860647-7000-45C8-8187-C70FAB98EBC4</gtr:id><gtr:impact>IP and patenting + publications</gtr:impact><gtr:outcomeId>C7B20B0AF70-1</gtr:outcomeId><gtr:partnerContribution>Provision of transgenic mouse models of AD</gtr:partnerContribution><gtr:piContribution>Develeopment of novel compounds as inhibitors for the Alzheimers beta-secretase</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Life Sciences</gtr:department><gtr:description>Advanced mass spectrometry for glycomics</gtr:description><gtr:id>6EEB08D4-EADC-47FE-A4AD-B423A5FE73FA</gtr:id><gtr:impact>Network grants and publications</gtr:impact><gtr:outcomeId>A35C98203E1-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on advanced glycan analysis by mass spectrometry</gtr:partnerContribution><gtr:piContribution>Provision of compounds for analysis by MS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Callaghan Innovation</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Carbohydrate Chemistry</gtr:department><gtr:description>Synthetic chemistry for HS analogues</gtr:description><gtr:id>D9F1B15F-1CA8-48F2-A45C-7560CB4A73FC</gtr:id><gtr:impact>Publication in JACS and Chem Euro Journal and ongoing collaborations</gtr:impact><gtr:outcomeId>92765CB861E-3</gtr:outcomeId><gtr:partnerContribution>Development of advanced synthetic chemistry to produce heparan sulphate saccharides Major contribution in kind through New Zealand government grants to fund their chemistry development</gtr:partnerContribution><gtr:piContribution>Design of target molecules for synthesis and provision of bioassays for screening</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences Liverpool</gtr:department><gtr:description>Glycomics strategies for heparan sulphates</gtr:description><gtr:id>365AB20A-5B50-47E3-8479-E3033FD5C443</gtr:id><gtr:impact>Publications, grants and ongoing research collaborations.</gtr:impact><gtr:outcomeId>D466AF5F0AA-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on molecular interactions and interactomics approaches.</gtr:partnerContribution><gtr:piContribution>Expertise on structure and activity relationships and glycomics strategies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Medical Biochemistry</gtr:department><gtr:description>Animal testing of AD secretase inhibitors</gtr:description><gtr:id>3EF57D35-3A11-4FA1-8757-EC8B3B62E640</gtr:id><gtr:impact>IP and patenting + publications</gtr:impact><gtr:outcomeId>C7B20B0AF70-3</gtr:outcomeId><gtr:partnerContribution>Provision of transgenic mouse models of AD</gtr:partnerContribution><gtr:piContribution>Develeopment of novel compounds as inhibitors for the Alzheimers beta-secretase</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Georgia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Synthetic chemistry for HS analogues</gtr:description><gtr:id>23CF6DB2-3A42-4163-BBAF-793A9C28C5AF</gtr:id><gtr:impact>Publication in JACS and Chem Euro Journal and ongoing collaborations</gtr:impact><gtr:outcomeId>92765CB861E-1</gtr:outcomeId><gtr:partnerContribution>Development of advanced synthetic chemistry to produce heparan sulphate saccharides Major contribution in kind through New Zealand government grants to fund their chemistry development</gtr:partnerContribution><gtr:piContribution>Design of target molecules for synthesis and provision of bioassays for screening</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Victoria University of Wellington</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Ferrier Research Institute</gtr:department><gtr:description>Synthetic chemistry for HS analogues</gtr:description><gtr:id>A6C2E56D-F9F1-4112-90F9-88D06EB31198</gtr:id><gtr:impact>Publication in JACS and Chem Euro Journal and ongoing collaborations</gtr:impact><gtr:outcomeId>92765CB861E-4</gtr:outcomeId><gtr:partnerContribution>Development of advanced synthetic chemistry to produce heparan sulphate saccharides Major contribution in kind through New Zealand government grants to fund their chemistry development</gtr:partnerContribution><gtr:piContribution>Design of target molecules for synthesis and provision of bioassays for screening</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Callaghan Innovation</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:description>Synthetic chemistry for heparan sulfate analogues</gtr:description><gtr:id>97DF3E83-ADEC-4AFB-BFB8-2AAB1878E43C</gtr:id><gtr:outcomeId>b96291cab96291e8-1</gtr:outcomeId><gtr:piContribution>International collaboration to develop synthetic chemistry for heparin/HS glycans</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Victoria University of Wellington</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Ferrier Research Institute</gtr:department><gtr:description>Development of AD therapeutics</gtr:description><gtr:id>1984BC13-E788-47E1-800D-B4595B079EE1</gtr:id><gtr:impact>Chem Eur J publication, further manuscripts in preparation, joint funding and IP patent submissions</gtr:impact><gtr:outcomeId>538307427a76f7.91630409-2</gtr:outcomeId><gtr:partnerContribution>Developing synthetic chemistry for BACE inhibitors and providing compounds and radiolabelled compounds</gtr:partnerContribution><gtr:piContribution>Providing target structures and bioassays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uppsala University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Medical Biochemistry and Microbiology</gtr:department><gtr:description>Animal testing of AD secretase inhibitors</gtr:description><gtr:id>08ADBE71-9E19-401F-9A86-4DBE9D62D15C</gtr:id><gtr:impact>IP and patenting + publications</gtr:impact><gtr:outcomeId>C7B20B0AF70-2</gtr:outcomeId><gtr:partnerContribution>Provision of transgenic mouse models of AD</gtr:partnerContribution><gtr:piContribution>Develeopment of novel compounds as inhibitors for the Alzheimers beta-secretase</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Industrial Research Ltd</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Glycochemistry Division</gtr:department><gtr:description>Synthetic chemistry for HS analogues</gtr:description><gtr:id>DF9DA517-33E8-4F7D-84CD-ABE236655ED0</gtr:id><gtr:impact>Publication in JACS and Chem Euro Journal and ongoing collaborations</gtr:impact><gtr:outcomeId>92765CB861E-2</gtr:outcomeId><gtr:partnerContribution>Development of advanced synthetic chemistry to produce heparan sulphate saccharides Major contribution in kind through New Zealand government grants to fund their chemistry development</gtr:partnerContribution><gtr:piContribution>Design of target molecules for synthesis and provision of bioassays for screening</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>RCUK/BBSRC event: Lifelong Health: Bioscience of Ageing (at Westminster)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E2560C24-8C40-4BF2-A692-60D8D8943C68</gtr:id><gtr:impact>Poster highlighting discovery of new class of drugs for AD at the RCUK/BBSRC event: 2007 Lifelong Health: Bioscience of Ageing (at Westminster)

Dissemination of information on research success to MPs and policymakers</gtr:impact><gtr:outcomeId>4FDB8F2C434</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media releases on research findings</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7AEE12E2-4A23-41F9-9109-FC537A903FBA</gtr:id><gtr:impact>University press releases on the novel Alzheimer drug hits we discovered, along with developments in synthetic chemistry of our sugars, and applications in nerve repair and cancer therapeutics

International press coverage, radio interviews (Radio City Liverpool), and TV news (BBC NW Tonight).</gtr:impact><gtr:outcomeId>664F9A23EAF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting visit to Liverpool University by local ARUK funding supporters</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DDFDA7DE-F6DF-4DF7-ADC6-C20AC3631F87</gtr:id><gtr:impact>Contact was invaluable in informing supporters directly about research activities supported in Liverpool by their fund raising efforts

Funding supporters were able to gain insights into new potential treatments for AD, and how their funding is used for research.</gtr:impact><gtr:outcomeId>53889ecec48c68.47147256</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture to Garston Rotary Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1E2ABA0D-80D2-4ABF-946C-12F87AEF19F9</gtr:id><gtr:impact>Lecture to Garston Rotary Club

Contributing the Public Understanding of Science</gtr:impact><gtr:outcomeId>E03C6115FF2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture to Liverpool Soroptimists Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E3816450-6DE0-4587-89B7-436D7C62F7CF</gtr:id><gtr:impact>Talk sparked many questions and discussion of AD and potential new drugs and diagnostics

Contribution to Public Understanding of Science</gtr:impact><gtr:outcomeId>5464a2a09d1b27.42175603</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Outreach to Business Community</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF687B25-C908-4A34-B5A7-BADB84F281B8</gtr:id><gtr:impact>Article in magazine Research Intelligence by UoL Business Gateway,(see website link &amp;quot;Sweet Smell of Success&amp;quot; http://www.liv.ac.uk/researchintelligence/issue30/alzheimers.html)

Dissemination of information to business community</gtr:impact><gtr:outcomeId>5ABD8E4DF77</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.liv.ac.uk/researchintelligence/issue30/alzheimers.html</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Supporting ARUK fund raising publicity with major London donor</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>62549004-50AA-4D67-895D-303C8722D4F4</gtr:id><gtr:impact>Supporters engaged directly with researcher undertaking research activity.

As above</gtr:impact><gtr:outcomeId>53889defdeaad5.02672164</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentships (3)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4CC47C59-5D42-4543-95EB-DDD82E4725BB</gtr:id><gtr:outcomeId>1597F9167E20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC/RCUK Basic Technology and Translation grants</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>3E7724A5-327F-41F4-A121-663CB2A37FA3</gtr:id><gtr:outcomeId>CDD9E9F69F90</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Research Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ECBEF4D7-4AF5-4306-AF9D-805943F7CE00</gtr:id><gtr:outcomeId>FA020A91DE40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>430000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical PhD Fellowship</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5BFD2CA6-1290-4641-B3CA-4B8D8E9D9A91</gtr:id><gtr:outcomeId>5464a6882100f7.56025869</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HFSP Grant</gtr:description><gtr:fundingOrg>Human Frontier Science Program (HFSP)</gtr:fundingOrg><gtr:id>03A4EED4-034B-4656-8759-F7D6BB7CCE94</gtr:id><gtr:outcomeId>53EA82566000</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:fundingOrg>MRC Headoffice</gtr:fundingOrg><gtr:id>12443CA2-9B59-4C75-BC5C-C282CEE6A1B9</gtr:id><gtr:outcomeId>5464a62529dcb3.03747838</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grants</gtr:description><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>6CD55EDB-267D-47A7-961F-F1BDAE22B928</gtr:id><gtr:outcomeId>2D77D0862160</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust project grants</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>94F7925A-B19F-45D9-80CE-B9CD0EB9EF19</gtr:id><gtr:outcomeId>FA1180133AB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>496000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CE01D07E-1019-4282-AA8A-1E499B663D92</gtr:id><gtr:outcomeId>HT84z6PzZPN0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Novel class of beta-secretase inhibitors based on natural heparin glycans, with potential as first in class disease-modifying treatment for AD</gtr:description><gtr:grantRef>G117/423</gtr:grantRef><gtr:id>63D7E0A9-8898-4BD1-9567-95D731C786BE</gtr:id><gtr:impact>IP licensed to University of Liverpool spinout IntelliHep and currently in further development</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>XZcP2tEr4cu</gtr:outcomeId><gtr:patentId>WO2007138263</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Beta-secretase inhibitors for Alzheimers disease</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Novel fully synthetic beta-secretase inhibitors with potential as disease-modifying treatment for AD</gtr:description><gtr:grantRef>G117/423</gtr:grantRef><gtr:id>D1405BF7-58F8-426B-AB04-4AD2E07DC2B4</gtr:id><gtr:impact>Further development being undertaken in collaboration with University of Liverpool, and spinout IntelliHep.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>sKGFToGQKWx</gtr:outcomeId><gtr:patentId>WO2012121617</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Synthetic beta-secretase inhibitors</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Patent submitted on novel saccharide inhibitors of beta-secretase as potential therapeutics for Alzheimers disease</gtr:description><gtr:grantRef>G117/423</gtr:grantRef><gtr:id>9F406BA1-E5E4-46FF-8815-175F1D614A22</gtr:id><gtr:impact>Licenced to IntelliHep Ltd, and ongoing patent costs will be paid by IntelliHep.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>m-9570957235.592379766a2f1c</gtr:outcomeId><gtr:patentId>WO2007/138263</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Saccharide inhibitors of beta-secretase</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Platform technology for generating selectively chemivcally modified heparins for drug discovery and biotechnology applications</gtr:description><gtr:grantRef>G117/423</gtr:grantRef><gtr:id>2D60EA7E-D7F3-4120-B848-CB818F36D0E0</gtr:id><gtr:impact>Licences to University of Liverpool spin out IntelliHep Ltd for exploitation.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>E9D4C264689</gtr:outcomeId><gtr:patentId>US2006240473</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Engineered heparins</gtr:title><gtr:yearProtectionGranted>2006</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Novel glycodendrimers with potent bioactivities, including inhibition of BACE1.</gtr:description><gtr:grantRef>G117/423</gtr:grantRef><gtr:id>7BDD7D9A-4B28-4B7F-95CC-EB93052A400C</gtr:id><gtr:impact>Still in early stage of development</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>5388984aadc598.72096154</gtr:outcomeId><gtr:patentId>PCT/NZ2012/000035</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Novel saccharide dendrimers</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Novel heparin-based compounds that inhibit the protease beta-secretase for intervention in Alzheimers disease. Could be first-in-class for targetting an underlying disease mechanism rather than simply secondary disease effects.</gtr:description><gtr:id>F0B2957E-1615-4704-BC52-669F52AFFDBB</gtr:id><gtr:impact>Still in development and has been licenced to a University of Liverpool spin-out company we created called IntelliHep Ltd.</gtr:impact><gtr:outcomeId>9DB6D16FAF0</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Beta-secretase inhibitor for AD treatment</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of technologies for and production of complex libraries of HS saccharides</gtr:description><gtr:id>3ABBC1A6-CB74-4CD1-8EEF-1B0575AC8B72</gtr:id><gtr:impact>Novel discoveries of structure-activity relationships for complex HS saccharides of relevance to biological and disease processes</gtr:impact><gtr:outcomeId>E4D9497A220</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Heparan sulphate saccharide libraries</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Developed a brain tissue slice ex vivo culture assay which allows screening of the effects of exogenous compounds on brain tissue biochemistry. This is particularly useful for obtaining data on the activity of for example BACE1 inhibitors on Abeta levels, using transgenic mouse models.</gtr:description><gtr:id>A88A4BD7-4459-4F96-B780-4DAE91C0AF95</gtr:id><gtr:impact>Publication in preparation for submission.</gtr:impact><gtr:outcomeId>53889cf9180df8.14721437</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Novel brain slice assays for ex vivo screening in transgenic mouse models</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Libraries of selectively chemically modified heparins for applications in heparin-based drug discovery.</gtr:description><gtr:id>4659F264-A2BC-46AF-AD65-16E5D7252F9A</gtr:id><gtr:impact>Exploited for a number of publications and to develop drug leads for AD, malaria, ant-cancer therapeutics and spinal repair therapies.</gtr:impact><gtr:outcomeId>CF594137A64</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Engineered heparins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>IntelliHep Ltd</gtr:companyName><gtr:description>Spin-out company from University of Liverpool aiming to exploit engineered heparins in drug discovery and biotechnology applications. Company has a number of collaborative projects with external partners, and is also developing an internal pipeline of projects. Company is pre-investment and established a lab in 2010 and seeking further grant and investment income.; http://www.intellihep.com/</gtr:description><gtr:id>4E6B46EB-FA9D-4B7D-8493-E28A4C72AF3C</gtr:id><gtr:impact>Early stage development of hit compounds as beta-secretase inhibitors for treating the underlying cause of Alzheimers disease. Option to licence IP from Liverpool University on an anticancer metastatic drug. Employment of research staff and regular funded projects sub-contracted into University labs. Collaborating with China partners on commercial applications of heparin by-products.</gtr:impact><gtr:outcomeId>1D2B8E8802C</gtr:outcomeId><gtr:url>http://www.intellihep.com/</gtr:url><gtr:yearCompanyFormed>2006</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>B48A33E3-57AC-4270-A56A-8E7EDE855FB8</gtr:id><gtr:title>Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.</gtr:title><gtr:parentPublicationTitle>Pediatric surgery international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d786766af912a1cf264e031e1e6b8239"><gtr:id>d786766af912a1cf264e031e1e6b8239</gtr:id><gtr:otherNames>Thompson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0179-0358</gtr:issn><gtr:outcomeId>7B516FE439D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D93B343-9EA1-48CF-B375-8634018D15EC</gtr:id><gtr:title>Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c3b7fef8dafe1d37d73127af64c17a7"><gtr:id>5c3b7fef8dafe1d37d73127af64c17a7</gtr:id><gtr:otherNames>Patey SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>4DC368FC6A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1057ED4-94DC-4A4F-A633-6C8894C26C22</gtr:id><gtr:title>Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed920437f418d218567bb635f85f09b2"><gtr:id>ed920437f418d218567bb635f85f09b2</gtr:id><gtr:otherNames>Bromfield S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546499ac7c1e19.46059338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09DC0E60-B1E2-473C-9546-839F68F5CF0B</gtr:id><gtr:title>High sensitivity separation and detection of heparan sulfate disaccharides.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/525f0aa9b75a329ba02b752c076c7854"><gtr:id>525f0aa9b75a329ba02b752c076c7854</gtr:id><gtr:otherNames>Skidmore MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>E6990A51698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4E5676B-7D9F-4907-8077-862A9C252DE1</gtr:id><gtr:title>Generating heparan sulfate saccharide libraries for glycomics applications.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e22a32a9ea715e6a3ab22dbfd6684919"><gtr:id>e22a32a9ea715e6a3ab22dbfd6684919</gtr:id><gtr:otherNames>Powell AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>8B79A91ED1B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D696A638-CD94-45F4-8DC4-CFB985D29C70</gtr:id><gtr:title>Fabrication of carbohydrate microarrays on gold surfaces: direct attachment of nonderivatized oligosaccharides to hydrazide-modified self-assembled monolayers.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6872f6960c5afb96eb5c4b6d2c3d2354"><gtr:id>6872f6960c5afb96eb5c4b6d2c3d2354</gtr:id><gtr:otherNames>Zhi ZL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>DB64B533BE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2BF704E-F176-49D3-8429-117AFB64A663</gtr:id><gtr:title>Array-based functional screening of heparin glycans.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01dd6d48ee833a5f06d83163d6525b21"><gtr:id>01dd6d48ee833a5f06d83163d6525b21</gtr:id><gtr:otherNames>Puvirajesinghe TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_16165_25_22633407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3307D48-D2FB-47E5-93A2-1EFE5695C6EA</gtr:id><gtr:title>Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b857b733f594992ba6c8a4087b72d8"><gtr:id>06b857b733f594992ba6c8a4087b72d8</gtr:id><gtr:otherNames>Theodoraki A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>546498c5e5fbe4.45643901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7D63C73-0153-4CB4-81B4-E1A19BB3642B</gtr:id><gtr:title>Versatile Separation and Analysis of Heparan Sulfate Oligosaccharides Using Graphitized Carbon Liquid Chromatography and Electrospray Mass Spectrometry.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b419b031de2e04c4ed5a45502b0e1e81"><gtr:id>b419b031de2e04c4ed5a45502b0e1e81</gtr:id><gtr:otherNames>Miller RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>5a2fcdb5923467.63285726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C31325C8-062D-4D37-9F51-62E3E436E6D0</gtr:id><gtr:title>Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/525f0aa9b75a329ba02b752c076c7854"><gtr:id>525f0aa9b75a329ba02b752c076c7854</gtr:id><gtr:otherNames>Skidmore MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_16165_25_21127491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>983DC212-8932-41AC-922E-944D12D7BACF</gtr:id><gtr:title>Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f51e190a92a1cba9a8042b8d614d69"><gtr:id>b4f51e190a92a1cba9a8042b8d614d69</gtr:id><gtr:otherNames>Guimond SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>E843C9787B8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7D11C2-166E-4483-9C64-22B7CF3A555B</gtr:id><gtr:title>Identification of Orally Available Synthetic Heparinoids with Potent BACE1 Inhibitory Properties</gtr:title><gtr:parentPublicationTitle>Nature Biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ff6f916a640dd4c53546bda256c381"><gtr:id>02ff6f916a640dd4c53546bda256c381</gtr:id><gtr:otherNames>Turnbull, JE</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>53889a3be21c88.21151337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A02DAE5-D118-4E05-8BC1-27A275114CE0</gtr:id><gtr:title>Chemistry. Getting the farm out of pharma for heparin production.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57b32cbe5f2a1d3281657bf15f25cbfb"><gtr:id>57b32cbe5f2a1d3281657bf15f25cbfb</gtr:id><gtr:otherNames>Turnbull JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_16165_25_22034422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BFE117F-5DF6-4BBE-808C-3D04E2797AB2</gtr:id><gtr:title>A versatile gold surface approach for fabrication and interrogation of glycoarrays.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6872f6960c5afb96eb5c4b6d2c3d2354"><gtr:id>6872f6960c5afb96eb5c4b6d2c3d2354</gtr:id><gtr:otherNames>Zhi ZL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>0297DFB4FD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6F7D59-37C1-4E7D-B47A-3A307BDCFAD4</gtr:id><gtr:title>Heparin Isomeric Oligosaccharide Separation Using Volatile Salt Strong Anion Exchange Chromatography.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b419b031de2e04c4ed5a45502b0e1e81"><gtr:id>b419b031de2e04c4ed5a45502b0e1e81</gtr:id><gtr:otherNames>Miller RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>585d35fa2dcaa6.40420723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02CAA528-9B3F-4B4C-8A7A-B4F91BFFE83E</gtr:id><gtr:title>Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244b86ec829ab877769ec997e4ed009b"><gtr:id>244b86ec829ab877769ec997e4ed009b</gtr:id><gtr:otherNames>Arungundram S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>A5C3724F86A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52801302-2428-4BC9-8F53-9E20749FC42E</gtr:id><gtr:title>Software tool for the structural determination of glycosaminoglycans by mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0db40194255c6ace68aa3e221566dc76"><gtr:id>0db40194255c6ace68aa3e221566dc76</gtr:id><gtr:otherNames>Tissot B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>F77CB471AC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A057BF6-E3D1-449C-9EE8-2B5766D4C2E6</gtr:id><gtr:title>A molecular mechanism for the heparan sulfate dependence of slit-robo signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4795e1f418d82c865c3669bb80d9b329"><gtr:id>4795e1f418d82c865c3669bb80d9b329</gtr:id><gtr:otherNames>Hussain SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>94A31C7FC01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E2876CE-B75A-41F1-80F6-A58C440C2982</gtr:id><gtr:title>Novel ex vivo transgenic mouse brain tissue assay for screening BACE1 inhibitors</gtr:title><gtr:parentPublicationTitle>Nature Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/092804ddacbc4778ce8b19029aa8303d"><gtr:id>092804ddacbc4778ce8b19029aa8303d</gtr:id><gtr:otherNames>Guimond, SE</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>5388995506e937.40738742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>459A70DC-C782-46B2-8BC5-2F5CB544D750</gtr:id><gtr:title>Oligosaccharide agents for treating Neurodegeneration</gtr:title><gtr:parentPublicationTitle>Patent WO2007/138263</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c216653e3a5e46bcdd1beb97b36eb008"><gtr:id>c216653e3a5e46bcdd1beb97b36eb008</gtr:id><gtr:otherNames>Patey S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>7A60D09A1D1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33B9F49E-02E7-4CE2-B7EE-0296AA527DF0</gtr:id><gtr:title>Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of ?-secretase: potential therapeutics for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50dd39d48ac6d8d38b428a78a915072c"><gtr:id>50dd39d48ac6d8d38b428a78a915072c</gtr:id><gtr:otherNames>Schw?rer R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>538305a2274854.91159051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92287551-2B9A-41B4-B0D0-FCCC31A37E08</gtr:id><gtr:title>Heparan sulphate glycodendrimers with potent bioactivities: tools for chemical biology and therapeutic development.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fb614b3ab31aae44505c52c29cd6243"><gtr:id>7fb614b3ab31aae44505c52c29cd6243</gtr:id><gtr:otherNames>Zubkova, O</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>53889af710c159.92263728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9709E1B4-64A4-4AF8-B91B-6FF9F688DF60</gtr:id><gtr:title>Engineered bio-active polysaccharides from heparin.</gtr:title><gtr:parentPublicationTitle>Macromolecular bioscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f51e190a92a1cba9a8042b8d614d69"><gtr:id>b4f51e190a92a1cba9a8042b8d614d69</gtr:id><gtr:otherNames>Guimond SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1616-5187</gtr:issn><gtr:outcomeId>DFBAB38D607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>385875AB-686E-419D-88DD-6EB354F08407</gtr:id><gtr:title>Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/558a73c42b43e2a74e4727d5253ac596"><gtr:id>558a73c42b43e2a74e4727d5253ac596</gtr:id><gtr:otherNames>Rudd TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn><gtr:outcomeId>57866EEAEE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAA80AF4-CADA-4318-BF20-B13EFA1EE55B</gtr:id><gtr:title>Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/957d08226fb425018378cd5ae23ccb1c"><gtr:id>957d08226fb425018378cd5ae23ccb1c</gtr:id><gtr:otherNames>Patel VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>1DAC2EB40E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E295E9E-F2A2-4C60-B0CA-C6A2749A7707</gtr:id><gtr:title>The geometric control of E14 and R1 mouse embryonic stem cell pluripotency by plasma polymer surface chemical gradients.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9883c655ef55c44619fdd0767fffac55"><gtr:id>9883c655ef55c44619fdd0767fffac55</gtr:id><gtr:otherNames>Wells N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>89DEB139CEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCC8017F-DFAA-41A5-AFCC-FC03DDE39643</gtr:id><gtr:title>Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0db40194255c6ace68aa3e221566dc76"><gtr:id>0db40194255c6ace68aa3e221566dc76</gtr:id><gtr:otherNames>Tissot B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn><gtr:outcomeId>8ADB6907674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>710B2CD9-803F-48AE-A9C2-049E0ABDB975</gtr:id><gtr:title>Synthetic sugars enhance the functional glycomics toolkit.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57b32cbe5f2a1d3281657bf15f25cbfb"><gtr:id>57b32cbe5f2a1d3281657bf15f25cbfb</gtr:id><gtr:otherNames>Turnbull JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>47B26039F9B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBF6ACD7-BBDA-4DB8-8E44-AC2E8A5F2520</gtr:id><gtr:title>Engineered heparins: novel beta-secretase inhibitors as potential Alzheimer's disease therapeutics.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c3b7fef8dafe1d37d73127af64c17a7"><gtr:id>5c3b7fef8dafe1d37d73127af64c17a7</gtr:id><gtr:otherNames>Patey SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>3C5A769EDC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29A5B0BF-18FD-4958-B44F-6BD4169712DB</gtr:id><gtr:title>Heparan sulfotransferases Hs6st1 and Hs2st keep Erk in check for mouse corpus callosum development.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30c494f9760ef19b516672d0e9341575"><gtr:id>30c494f9760ef19b516672d0e9341575</gtr:id><gtr:otherNames>Clegg JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>54649a86ccc641.58420228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF919EA-83FD-4283-81FA-60E3B082D97D</gtr:id><gtr:title>Extracellular regulation of developmental cell signaling by XtSulf1.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0f1a793db16a455db9d28894e0e9cd9"><gtr:id>c0f1a793db16a455db9d28894e0e9cd9</gtr:id><gtr:otherNames>Freeman SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>51EABF8F9BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB690A19-AD29-45E4-AFCD-6169FF3DA1BE</gtr:id><gtr:title>Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?</gtr:title><gtr:parentPublicationTitle>BMC developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d786766af912a1cf264e031e1e6b8239"><gtr:id>d786766af912a1cf264e031e1e6b8239</gtr:id><gtr:otherNames>Thompson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-213X</gtr:issn><gtr:outcomeId>pm_16165_25_21672206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4EE35B-CA7C-4A0D-9194-F43EAA035491</gtr:id><gtr:title>Glycomics profiling of heparan sulfate structure and activity.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57b32cbe5f2a1d3281657bf15f25cbfb"><gtr:id>57b32cbe5f2a1d3281657bf15f25cbfb</gtr:id><gtr:otherNames>Turnbull JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_16165_25_20816205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46C498B5-A08D-4294-9C5A-A3D751E72F2C</gtr:id><gtr:title>MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0851f0f18a00110fa342dcbd107d52a2"><gtr:id>0851f0f18a00110fa342dcbd107d52a2</gtr:id><gtr:otherNames>Solari V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>546495e6e16561.26208827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D90CFE6-A52B-45BE-826B-B31CBD27B179</gtr:id><gtr:title>Heparan sulfate glycomics: towards systems biology strategies.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57b32cbe5f2a1d3281657bf15f25cbfb"><gtr:id>57b32cbe5f2a1d3281657bf15f25cbfb</gtr:id><gtr:otherNames>Turnbull JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_16165_25_20863313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51CFCFF8-AD29-4621-842E-0CA946204F61</gtr:id><gtr:title>Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aea2026741a3964fcc7ec26cbdba5794"><gtr:id>aea2026741a3964fcc7ec26cbdba5794</gtr:id><gtr:otherNames>Higginson JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_16165_25_23136428</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G117/423</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>